NanoDetection and Oligomerix Sign Global Licensing Deal for Neurodegenerative Disease Antibodies

NanoDetection Technology and Oligomerix Enter Exclusive Global Licensing Agreement to Advance Next-Generation Neurodegenerative Disease Diagnostics NanoDetection Technology, Incorporated (NDT) and Oligomerix, Inc. have announced a significant strategic partnership through the execution of an exclusive worldwide licensing agreement focused on advancing…










